Literature DB >> 9448686

Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.

S A González1, J L Affranchino.   

Abstract

In the late stages of replication of the simian immunodeficiency viruses (SIV), the matrix protein (MA) plays a central role in the transport of Pr55gag to the plasma membrane, assembly of virus particles, and incorporation of the envelope glycoprotein into particles. Targeting of Pr55gag to the plasma membrane is mediated by two motifs within the MA protein: the N-terminal myristate and a cluster of positively charged amino acids. In this report, we characterized the assembly phenotype of an SIV Gag mutant (L8Q) carrying the single amino acid substitution of glutamine for leucine at position 8 in the MA domain. The hydropathic profile of the mutated MA protein indicated that the L8Q amino acid change disrupts the hydrophobic character of the region comprising the first 10 residues of the protein. Expression of mutant L8Q Gag protein in CV-1 cells, by means of the vaccinia virus vector system, resulted in efficient synthesis and N-myristylation of Pr55gag. However, this mutation severely impaired particle production, as inferred from both biochemical and electron microscopy analyses. Cellular fractionation assays revealed that in cells expressing mutant L8Q, the proportion of cytosol-associated Pr55gag was significantly increased compared to that observed upon expression of wild-type Gag. Furthermore, mutant L8Q Gag partitioned onto cytosol and membrane fractions in a manner similar to nonmyristylated Gag polyprotein. Taken together, these results indicate that the L8Q mutation reduces the membrane-binding capacity of the Gag precursor. It is therefore likely that in the SIV MA, in addition to the N-myristate group, the hydrophobicity of the neighboring region is important for efficient association of Pr55gag with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448686     DOI: 10.1006/viro.1997.8919

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Point mutations in the HIV-1 matrix protein turn off the myristyl switch.

Authors:  Jamil S Saad; Erin Loeliger; Paz Luncsford; Mellisa Liriano; Janet Tai; Andrew Kim; Jaime Miller; Anjali Joshi; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2006-12-01       Impact factor: 5.469

3.  Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.

Authors:  J C Paillart; H G Göttlinger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.

Authors:  Julieta M Manrique; Cristina C P Celma; Eric Hunter; José L Affranchino; Silvia A González
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Analysis of bovine leukemia virus gag membrane targeting and late domain function.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 6.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

Review 7.  Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency viruses.

Authors:  José L Affranchino; Silvia A González
Journal:  Viruses       Date:  2014-01-16       Impact factor: 5.048

8.  Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein.

Authors:  María J Esteva; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

9.  Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor.

Authors:  César A Ovejero; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.